← Back to headlines
Cogent Bioscience Files New Drug Application for Bezuclastinib
Cogent Bioscience (COGT) has submitted a New Drug Application (NDA) for its drug candidate Bezuclastinib, marking a key step towards potential regulatory approval.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
